PI3K/AKT signaling pathway: new strategies for treating atherosclerosis with plant-derived compounds
Authors:
Open Access
- 19 March 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1722493
Abstract
Atherosclerosis (AS) is a chronic vascular inflammatory disease driven by lipid deposition, whose clinical management remains constrained by the limitations of existing pharmacological interventions. This review systematically elucidates the molecular mechanisms by which plant-derived compounds modulate AS through targeted regulation of the phosphoinositide-3-kinase/protein kinase B (PI3K/AKT) signaling pathway. Studies indicate that plant-derived compounds—such as terpenoids (e.g., artemisinin and tanshinone IIA) and alkaloids (e.g., berberine)—effectively attenuate the progression of AS via bidirectional modulation of the PI3K/AKT pathway. In early stages, suppression of this pathway downregulates downstream mechanistic target of rapamycin (mTOR) and nuclear factor-kappa B (NF-κB) protein expression, thereby mitigating inflammatory responses and lipid accumulation to inhibit plaque formation. Conversely, during advanced disease phases, moderate activation of the pathway upregulates key effectors, including autophagy-related protein (Beclin-1), glutathione (GSH), and glutathione peroxidase 4 (GPX4), promoting ferroptosis and autophagy in abnormal cells and thereby enhancing the stability of established plaques. It is noteworthy that the low bioavailability of plant-derived compounds and the stage-specific nature of pathway modulation remain critical challenges for clinical translation. In this review, we deepen the mechanistic understanding of plant-based interventions against AS and provide a theoretical foundation and innovative perspectives for the development of future botanically derived AS therapeutics.Keywords
This publication has 147 references indexed in Scilit:
- Wogonin Attenuates Atherosclerosis via KLF11‐Mediated Suppression of PPARα‐YAP1‐Driven Glycolysis and Enhancement of ABCA1/G1‐Mediated Cholesterol EffluxAdvanced Science, 2025
- Matrine Alleviates Atherosclerosis by Targeting REG1A and Activating the PI3K/AKT/mTOR Pathway to Inhibit Endothelial Cell FerroptosisBiochemical Genetics, 2025
- Oxidative Stress and Inflammation in Myocardial Ischemia–Reperfusion Injury: Protective Effects of Plant‐Derived Natural Active CompoundsJournal of Applied Toxicology, 2024
- Ferroptosis: Latest evidence and perspectives on plant‐derived natural active compounds mitigating doxorubicin‐induced cardiotoxicityJournal of Applied Toxicology, 2024
- Notoginsenoside R1 decreases intraplaque neovascularization by governing pericyte‐endothelial cell communication via Ang1/Tie2 axis in atherosclerosisPhytotherapy Research, 2024
- Stilbenes: a journey from folklore to pharmaceutical innovationArchives of Microbiology, 2024
- Development and safety of PI3K inhibitors in cancerArchives of Toxicology, 2023
- Class I PI3K Biology2022
- Modulatory action of withaferin‐A on oxidative damage through regulation of inflammatory mediators and apoptosis via PI3K/AKT signaling pathway in high cholesterol‐induced atherosclerosis in experimental ratsJournal of Biochemical and Molecular Toxicology, 2022
- Urolithins, gut microbiota‐derived metabolites of ellagitannins, inhibit LPS‐induced inflammation in RAW 264.7 murine macrophagesMolecular Nutrition & Food Research, 2015